Screener
DaVita DVA G&A
G&A at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by DaVita in its filing.
Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.
The source filing: DaVita’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 5:03 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000927066-26-000062
| Line item | Three months ended March 31, 2026 | Three months ended March 31, 2025 |
|---|---|---|
| Total revenues | 3,415,548 | 3,223,529 |
| Operating expenses: | ||
| Patient care costs | 2,342,257 | 2,239,660 |
| General and administrative | 421,914 | 374,090 |
| Depreciation and amortization | 177,829 | 176,451 |
| Equity investment income, net | (8,344) | (5,609) |
| Total operating expenses | 2,933,656 | 2,784,592 |
| Operating income | 481,892 | 438,937 |
Item 1. Condensed Consolidated Financial Statements:
FAQ
- What is DaVita's G&A?
- DaVita (DVA) reported G&A of $421.91M in Q1 2026.
- How has DaVita's G&A changed year-over-year?
- DaVita's G&A increased by 12.8% year-over-year, from $374.09M to $421.91M.
- What is the long-term trend for DaVita's G&A?
- Over 4 years (2021 to 2025), DaVita's G&A has grown at a 8.8% compound annual growth rate (CAGR), from $1.2B to $1.67B.
- What does G&A mean?
- Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.
Ask your AI about DaVita's g&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude